October
25
 

A second look at PGD

A technique for detecting abnormalities in embryos may have been giving misleading results, according to papers presented at a Montreal conference of US and Canadian fertility doctors. In pre- implantation genetic diagnosis (PGD) one cell from an eight-cell embryo is extracted and examined for abnormalities. If an embryo appears to be healthy, it is implanted in the mother's womb. If not, it is usually discarded. Children born after the technique appear to be healthy, although there are no long-term studies.

However, it now appears that defective embryos are able to correct defects as they mature. One American experiment discovered that about half of the cells in "defective" embryos were normal by the blastocyst stage. This suggested two things to the fertility specialists. First, that defective embryos might be a viable source of embryonic stem cells, and second, that many embryos discarded as defective could have developed into healthy babies.

One initiative to emerge from the meeting is a US database to track the safety of PGD. American clinics are not presently required to report their data.


comments powered by Disqus
 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Best of the web

 Recent Posts
Italy passes controversial end-of-life bill
16 Dec 2017
A transplant surgeon’s autograph book
16 Dec 2017
Utility or happiness? A case study from Detroit
16 Dec 2017
Adverse IVF incidents rise in UK: report
16 Dec 2017
Is infertility a disease?
16 Dec 2017

Home | About Us | Contact Us | rss RSS | Archive | Bookmark and Share | michael@bioedge.org

BioEdge - New Media Foundation Ltd © 2004 - 2009 All rights reserved -- Powered by Encyclomedia